FDA And FTC Join Forces On Biosimilars

Teaming Up To Eliminate Barriers To Biosimilar Competition

 
• By Brenda Sandburg
  
Conceptual business illustration with the words anti-competitive practices
FDA and FTC to target anticompetitive behavior that impedes access to biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products